CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vivos Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vivos Inc
719 Jadwin Ave
Phone: (509) 736-4000p:509 736-4000 RICHLAND, WA  99352-4217  United States Ticker: ADMD ADMD
Business Summary
Vivos Inc. is a radiation oncology medical device company. The Company has developed an Yttrium-90-based injectable Precision Radionuclide Therapy medical device to treat tumors in animals (IsoPet) and humans (RadioGel). Using the Company’s proprietary hydrogel technology, PRnT uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area. The injection delivers therapeutic radiation from within the tumor without the entrance skin dose and associated side effects of treatment that characterize external-beam radiation therapy. This feature allows the safe delivery of higher doses needed for treating non-resectable and radiation-resistant cancers. University veterinary hospitals use the IsoPet Solutions division to demonstrate animal cancers’ safety and therapeutic effectiveness. RadioGel is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202512/31/2024YesYes---

Industries
SIC Code Description
2810 Industrial inorganic chemicals
3844 X-ray apparatus and tubes and related irradiation apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Secretary Carlton M.Cadwell 79 12/14/2016 1/1/2006
President, Chief Executive Officer, Director Michael K.Korenko 77 8/1/2017 5/12/2009
Interim Chief Financial Officer MichaelPollack 57 12/1/2018 12/1/2018

Business Names
Business Name
ADMD
ADMDD
ADVANCED MEDICAL ISOTOPE Corp
5 additional Business Names available in full report.

General Information
Number of Employees: 10 (As of 9/30/2013)
Outstanding Shares: 453,512,228 (As of 5/9/2025)
Shareholders: 232
Stock Exchange: OTC
Federal Tax Id: 800138937
Fax Number: (509) 736-4007


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, June 3, 2025